Patent applications of Beijing Biosis Healing Biological Technology Co., Ltd. are authorized in the United States and Germany

by

Patent applications of Beijing Biosis Healing Biological Technology Co., Ltd. (hereinafter referred to as Biosis Healing) are authorized in the United States and German. The two patents are extensions of PCT international application for animal-derived biotechnology of Biosis Healing to the United States and Germany. The two patents passed the substantive examination of the two national patent offices mentioned above respectively. The patent were authorized in the United States in May 2017 and have also entered the authorization process in Germany.

According to biotechnology global layout of Biosis Healing, the biotechnology involved in this patent has been extended to a number of countries including the United States, Germany, Japan, and Britain through PCT international applications. The authorization of the above two patents indicates that Biosis Healing has completed an important step in the global patent layout, and it is also a great affirmation of biotechnology advanced level of Biosis Healing.